Search

Your search keyword '"Mayer-Hamblett, Nicole"' showing total 486 results

Search Constraints

Start Over You searched for: Author "Mayer-Hamblett, Nicole" Remove constraint Author: "Mayer-Hamblett, Nicole"
486 results on '"Mayer-Hamblett, Nicole"'

Search Results

1. From Estimands to Robust Inference of Treatment Effects in Platform Trials

2. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.

5. Standards for the care of people with cystic fibrosis; establishing and maintaining health

7. Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective

11. A Novel Tool to Evaluate the Accuracy of Predicting Survival in Cystic Fibrosis

12. Statistical approaches for the integration of external controls in a cystic fibrosis clinical trial: a simulation and an application.

13. Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis.

16. Residual Weighted Learning for Estimating Individualized Treatment Rules

19. The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC Study

20. The future of cystic fibrosis care: a global perspective

21. Standards for the care of people with cystic fibrosis; establishing and maintaining health

23. Standards for the care of people with cystic fibrosis; establishing and maintaining health

30. Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study

32. Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study

35. Lung Function Decline in Cystic Fibrosis: Impact of Data Availability and Modeling Strategies on Clinical Interpretations

43. Assessing Safety of Discontinuing Hypertonic Saline in Those with Lower Forced Expiratory Volume in 1 Second after Elexacaftor/Tezacaftor/Ivacaftor.

Catalog

Books, media, physical & digital resources